How many FDA warning letters has Pharmathen International S.A. received?

Argus HQ has recorded 1 FDA warning letter for Pharmathen International S.A..

What FDA recalls has Pharmathen International S.A. issued?

Argus HQ has not recorded an FDA recall tied to Pharmathen International S.A. in our current dataset.

Is Pharmathen International S.A. FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Pharmathen International S.A.. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Pharmathen International S.A.

Name: FDA Enforcement Actions Against Pharmathen International S.A.
Creator: Argus HQ
License: https://argushq.ai/methodology

Industry: pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_warning_letter · cgmp2026-05-27
Pharmathen International S.A. — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-05-27)
fda_483 · inspection_citation2025-11-21
Pharmathen International S.A. -- FDA 483: 1 observation (2025-11-21)

Frequently asked questions

How many FDA warning letters has Pharmathen International S.A. received?: Argus HQ has recorded 1 FDA warning letter for Pharmathen International S.A..
What FDA recalls has Pharmathen International S.A. issued?: Argus HQ has not recorded an FDA recall tied to Pharmathen International S.A. in our current dataset.
Is Pharmathen International S.A. FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Pharmathen International S.A.. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.